LONTRA LIMITED

Their core work

Lontra Limited is a UK engineering SME that designed and commercialised the PureBlade compressor — a clean-sheet rotary compressor that delivers oil-free compressed air for industrial applications. Their technology targets hygienic manufacturing environments where air purity is non-negotiable, specifically food and drink production lines and pharmaceutical facilities. The core value proposition combines contamination elimination (no oil in the air supply) with reduced energy consumption compared to conventional compressor designs. Both of their EU-funded projects represent a single, focused technology development pathway taken from feasibility through to commercial-scale development.

What they specialise in

How they've shifted over time

Lontra's H2020 record is not a story of diversification — it is a single-technology maturation arc. In 2016 they validated the PureBlade concept with a Phase 1 feasibility study covering both food/pharma sectors. By 2017 they had narrowed the commercial focus to food and drinks production, which is a larger and more immediately accessible market than pharma. There are no keywords available to trace finer shifts, but the budget jump from €50K to €1.57M and the tighter sector framing in Phase 2 suggests the company sharpened its go-to-market positioning based on Phase 1 findings.

Lontra is on a commercialisation trajectory with a mature, fully EU-validated technology — a potential partner for system integrators, OEM compressor buyers, or food industry equipment suppliers rather than for basic research consortia.

How they like to work

Lontra has operated entirely as a solo coordinator on both projects — a pattern typical of the SME Instrument scheme, which is designed for individual companies rather than consortia. They have zero recorded consortium partners across their full H2020 history, meaning there is no established network of co-developers or research allies to tap into. Working with Lontra would likely mean engaging them as a technology provider or licensee rather than as a consortium co-applicant.

Lontra has no recorded consortium partners and has not collaborated with organisations in any other country under H2020. Their EU project footprint is that of a sole innovator, not a network node.

What sets them apart

Lontra is one of the few SMEs to have taken a proprietary compressor architecture from a clean-sheet concept all the way through EU-funded Phase 2 commercialisation, with €1.57M in public validation behind a single technology. That funding track record signals technical credibility and de-risked IP for potential industrial partners. For a consortium looking for a specialist compressed-air or energy-efficiency technology component, Lontra brings a finished, commercially-oriented product rather than early-stage research.

Highlights from their portfolio

• PureBlade (Phase 2)
  The largest grant (€1,572,616) and the full commercial development phase of the PureBlade compressor, covering low-energy pure air supply specifically for food and drinks production lines.
• PureBlade (Phase 1)
  The €50K feasibility study that successfully unlocked Phase 2 funding, demonstrating the technology's viability for both food and pharmaceutical air-purity applications.